Evans; David Michael
Patent Applications and Registrations
Patent applications and USPTO patent grants for Evans; David Michael.The latest application filed is for "orchestrated intelligent supply chain optimizer".
Company Profile
14.23.38
- Evans; David Michael - Welwyn Garden City GB
- EVANS; David Michael - Salisbury GB
- Evans; David Michael - Porton Down GB
- EVANS; David Michael - Wiltshire GB
- EVANS; David Michael - Sedgley GB
- Evans; David Michael - Southampton GB
- Evans; David Michael - St. Denys GB
- Evans; David Michael - Suthampton GB
- Evans, David Michael - Suthmapton GB
Patent Activity
| Patent | Date |
|---|---|
| Orchestrated Intelligent Supply Chain Optimizer App 20220309436 - Evans; David Michael ; et al. | 2022-09-29 |
| Enzyme Inhibitors App 20220298141 - DAVIE; Rebecca Louise ; et al. | 2022-09-22 |
| Enzyme Inhibitors App 20220298138 - DAVIE; Rebecca Louise ; et al. | 2022-09-22 |
| Enzyme Inhibitors App 20220289727 - CHILDS; Mitchell Lewis ; et al. | 2022-09-15 |
| N-((HET)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Kallikrein Inhibitors App 20220289729 - Davie; Rebecca Louise ; et al. | 2022-09-15 |
| Inhibitors Of Plasma Kallikrein App 20220153724 - Edwards; Hannah Joy ; et al. | 2022-05-19 |
| Enzyme Inhibitors App 20220048894 - DAVIE; Rebecca Louise ; et al. | 2022-02-17 |
| Inhibitors of plasma kallikrein Grant 11,242,333 - Edwards , et al. February 8, 2 | 2022-02-08 |
| Enzyme Inhibitors App 20220002275 - Davie; Rebecca Louise ; et al. | 2022-01-06 |
| N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors Grant 11,198,691 - Davie , et al. December 14, 2 | 2021-12-14 |
| Pyrazole derivatives as plasma kallikrein inhibitors Grant 11,180,484 - Davie , et al. November 23, 2 | 2021-11-23 |
| N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors Grant 11,084,809 - Davie , et al. August 10, 2 | 2021-08-10 |
| Orchestrated Intelligent Supply Chain Optimizer App 20210158259 - Evans; David Michael ; et al. | 2021-05-27 |
| N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors Grant 11,001,578 - Davie , et al. May 11, 2 | 2021-05-11 |
| N-((HET)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Kallikrein Inhibitors App 20200361923 - Davie; Rebecca Louise ; et al. | 2020-11-19 |
| Solid Forms Of A Plasma Kallikrein Inhibitor And Salts Thereof App 20200325116 - CROWE; David Malcolm ; et al. | 2020-10-15 |
| N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors Grant 10,781,181 - Evans , et al. Sept | 2020-09-22 |
| N-((HET)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Kallikrein Inhibitors App 20200199116 - Davie; Rebecca Louise ; et al. | 2020-06-25 |
| N-((het)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors Grant 10,611,758 - Davie , et al. | 2020-04-07 |
| N-((het)arylmethyl)-heteroaryl-carboxamides Compounds As Kallikrein Inhibitors App 20190330200 - Davie; Rebecca Louise ; et al. | 2019-10-31 |
| N-((HET)Arylmethyl)-Heteroaryl-Carboxamides Compounds As Plasma Kallikrein Inhibitors App 20190300517 - Davie; Rebecca Louise ; et al. | 2019-10-03 |
| N-((het) arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors Grant 10,364,238 - Davie , et al. | 2019-07-30 |
| Pyrazole Derivatives As Plasma Kallikrein Inhibitors App 20190218205 - DAVIE; Rebecca Louise ; et al. | 2019-07-18 |
| Hydraulic Screw Tensioner App 20190210203 - EVANS; David Michael ; et al. | 2019-07-11 |
| Inhibitors Of Plasma Kallikrein App 20190152950 - Edwards; Hannah Joy ; et al. | 2019-05-23 |
| Inhibitors of plasma kallikrein Grant 10,221,161 - Edwards , et al. | 2019-03-05 |
| N-((het) Arylmethyl)-heteroaryl-carboxamides Compounds As Plasma Kallikrein Inhibitors App 20180319782 - DAVIE; Rebecca Louise ; et al. | 2018-11-08 |
| Benzylamine derivatives Grant 9,834,513 - Allan , et al. December 5, 2 | 2017-12-05 |
| N-((het) Arylmethyl)-heteroaryl-carboxamides Compounds As Plasma Kallikrein Inhibitors App 20170305863 - EVANS; David Michael ; et al. | 2017-10-26 |
| Benzylamine Derivatives App 20170253561 - Allan; Christine Elizabeth ; et al. | 2017-09-07 |
| Bicyclic inhibitors Grant 9,738,641 - Edwards , et al. August 22, 2 | 2017-08-22 |
| Benzylamine derivatives Grant 9,670,157 - Allan , et al. June 6, 2 | 2017-06-06 |
| Heterocyclic derivates Grant 9,533,987 - Davie , et al. January 3, 2 | 2017-01-03 |
| Bicyclic Inhibitors App 20160185773 - EDWARDS; Hannah Joy ; et al. | 2016-06-30 |
| Inhibitors Of Plasma Kallikrein App 20160168123 - EDWARDS; Hannah Joy ; et al. | 2016-06-16 |
| Heterocyclic Derivates App 20160108036 - DAVIE; Rebecca Louise ; et al. | 2016-04-21 |
| Benzylamine Derivatives App 20160039752 - ALLAN; Christine Elizabeth ; et al. | 2016-02-11 |
| Benzylamine derivatives as inhibitors of plasma kallikrein Grant 9,234,000 - Evans , et al. January 12, 2 | 2016-01-12 |
| Benzylamine Derivatives As Inhibitors Of Plasma Kallikrein App 20150225450 - EVANS; DAVID MICHAEL ; et al. | 2015-08-13 |
| Benzylamine derivatives as inhibitors of plasma kallikrein Grant 9,051,249 - Evans , et al. June 9, 2 | 2015-06-09 |
| Benzylamine Derivatives As Inhibitors Of Plasma Kallikrein App 20140213611 - Evans; David Michael ; et al. | 2014-07-31 |
| FAP inhibitors Grant 8,183,280 - Evans , et al. May 22, 2 | 2012-05-22 |
| FAP inhibitors App 20100081701 - EVANS; David Michael | 2010-04-01 |
| Aminopyridine Derivatives App 20100076015 - Evans; David Michael ; et al. | 2010-03-25 |
| Selective dipeptide inhibitors of kallikrein Grant 7,649,000 - Evans January 19, 2 | 2010-01-19 |
| Non-peptide GnRH antagonists App 20080255109 - Roe; Michael Bryan ; et al. | 2008-10-16 |
| Non-peptide GnRH antagonists Grant 7,365,065 - Roe , et al. April 29, 2 | 2008-04-29 |
| Inhibitors of dipeptidyl peptidase IV Grant 7,189,728 - Evans , et al. March 13, 2 | 2007-03-13 |
| Antidiabetic agents Grant 7,169,806 - Evans January 30, 2 | 2007-01-30 |
| Inhibitors of dipeptidyl peptidase IV Grant 7,125,863 - Evans , et al. October 24, 2 | 2006-10-24 |
| Selective dipeptide inhibitors of kallikrein App 20060052313 - Evans; David Michael | 2006-03-09 |
| Non-peptide gnrh antagonists App 20050222139 - Roe, Michael Bryan ; et al. | 2005-10-06 |
| Novel antidiabetic agents App 20050203031 - Evans, David Michael | 2005-09-15 |
| Antidiabetic agents Grant 6,911,467 - Evans June 28, 2 | 2005-06-28 |
| 3-fluoro-pyrrolidines as antidiabetic agents App 20040235752 - Pitt, Gary Robert William ; et al. | 2004-11-25 |
| Inhibitors of dipeptidyl peptidase IV App 20040082497 - Evans, David Michael ; et al. | 2004-04-29 |
| Inhibitors of dipeptidyl peptidase IV App 20030216450 - Evans, David Michael ; et al. | 2003-11-20 |
| Novel antidiabetic agents App 20030096857 - Evans, David Michael | 2003-05-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 